Longeveron Inc. Provides Corporate Update and Reports First Quarter 2023 Financial Results
— New long-term survival data disclosed from ELPIS I trial of Lomecel-BTM for Hypoplastic Left…
News
SCYNEXIS Reports Closing of Exclusive License Agreement with GSK for BREXAFEMME® (Ibrexafungerp Tablets)
SCYNEXIS is receiving an upfront payment of $90 million with future performance-based milestone payments of…
Adaptive Biotechnologies to Participate in the 2023 RBC Capital Markets Global Healthcare Conference
SEATTLE, May 12, 2023 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a…
Landos Biopharma Provides Business Update and Reports First Quarter 2023 Results
NEXUS Phase 2 Clinical Trial of NX-13 for Ulcerative Colitis Initiated NEXUS Top-line Results Planned…
MoonLake Immunotherapeutics Reports First Quarter 2023 Financial Results and Provides a Business Update
MoonLake Immunotherapeutics Reports First Quarter 2023 Financial Results and Provides a Business Update Capital Markets…
Psychedelic Science 2023 Announces Sessions and Select Featured Speakers for the Therapy and Practitioners Tracks for June Conference
Dr. Rachel Yehuda to Lead Discussions on Therapeutic Application of Psychedelics Additional Featured Speakers Include…
LifeMD, Inc. Reports First Quarter 2023 Results; Record Revenues and Adjusted EBITDA
Record first quarter 2023 consolidated revenue of $33.1 million, up 14% from the same year-ago…
Humacyte First Quarter 2023 Financial Results and Business Update
– Human Acellular Vessel™ (HAV™) granted second RMAT designation by the FDA, for Vascular Trauma…
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2023
– Strong clinical momentum and cash runway into 2026 to support multiple clinical readouts across…
Bio-Path Holdings Reports First Quarter 2023 Financial Results
Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, May 12, 2023 (GLOBE…
Decibel Therapeutics Announces Approval of Clinical Trial Application by the Spanish Agency of Medicines and Medical Devices (AEMPS) to Initiate Clinical Development of Lead Gene Therapy Candidate DB-OTO
CTA authorization provides approval for the Company to expand its planned CHORD™ Phase 1/2 clinical…
Plus Therapeutics to Present in EndBrainCancer Initiative Virtual Educational Event
AUSTIN, Texas, May 12, 2023 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…
2023 Corporate Goodness Awards Celebrate Innovators in Social Impact
Benevity recognizes leading-edge brands for outstanding approaches to social impact, employee engagement and corporate philanthropy…
GlobalBlock Announces $715,000 Closing of Non-Brokered Private Placement
London, United Kingdom and Vancouver, British Columbia–(Newsfile Corp. – May 12, 2023) – GlobalBlock Digital…
MindMics Launches Heart Health System to Provide Accurate, Non-Invasive Heart Monitoring Regardless of Skin Tone or Body Mass Using Novel In-Ear Infrasonic Hemodynography (IH) Technology
Cambridge, Massachusetts–(Newsfile Corp. – May 12, 2023) – Today, MindMics, Inc. is pleased to announce…
Pflugerville Motorcycle Injury Claim Service Announced by Austin Accident Lawyer
Austin, Texas–(Newsfile Corp. – May 12, 2023) – Austin Accident Lawyer (+1-512-246-9191) has announced that…
Thousands of energy leaders gather in Manila to transform the future of renewable energy in the Philippines
Manila, Philippines, May 12, 2023 – (ACN Newswire) – The Future Energy Show & Solar…
Wells Fargo Announces Transition Information for Outstanding U.S. Dollar LIBOR-Linked Instruments
SAN FRANCISCO–(BUSINESS WIRE)–Wells Fargo & Company (NYSE: WFC) (“Wells Fargo”) and certain of its consolidated…
Kerrigan Advisors Represents Beck & Masten Auto Group in Sale of Three High Volume Buick GMC Dealerships to Group 1 Automotive
Sale of Texas Buick GMC dealerships highlights strong demand for top volume franchises in states…
Mannatech Reports First Quarter End 2023 Financial Results
FLOWER MOUND, Texas–(BUSINESS WIRE)–Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to…